Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Screeners that run automatically... and then email you the results! FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Sensus Healthcare Inc (SRTS)

Sensus Healthcare Inc (SRTS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Wall Street Analysts Predict a 72.6% Upside in Sensus Healthcare, Inc. (SRTS): Here's What You Should Know

The consensus price target hints at a 72.6% upside potential for Sensus Healthcare, Inc. (SRTS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings...

SRTS : 8.96 (+1.24%)
How 2022's Biggest Healthcare Gainers Could Fare In 2023

Health care stocks were hit hard early in the pandemic but these three have made quite a comeback. This article examines where they could go in 2023

SGFY : 28.61 (-0.97%)
SRTS : 8.96 (+1.24%)
HAE : 87.90 (-2.86%)
CVS : 87.66 (+2.23%)
Down 46.9% in 4 Weeks, Here's Why Sensus Healthcare, Inc. (SRTS) Looks Ripe for a Turnaround

Sensus Healthcare, Inc. (SRTS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts...

SRTS : 8.96 (+1.24%)
Sensus Healthcare, Inc. (SRTS) Q3 Earnings Lag Estimates

Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of -8.33% and 1.07%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

SRTS : 8.96 (+1.24%)
RXST : 13.19 (+2.25%)
SeaSpine Holdings (SPNE) Reports Q3 Loss, Tops Revenue Estimates

SeaSpine (SPNE) delivered earnings and revenue surprises of -40% and 0.34%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

SPNE : 9.54 (+8.29%)
SRTS : 8.96 (+1.24%)
Recent Price Trend in Sensus Healthcare, Inc. (SRTS) is Your Friend, Here's Why

Sensus Healthcare, Inc. (SRTS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed...

SRTS : 8.96 (+1.24%)
Edwards Lifesciences (EW) Lags Q3 Earnings and Revenue Estimates

Edwards Lifesciences (EW) delivered earnings and revenue surprises of -1.61% and 1.32%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

EW : 78.21 (+0.67%)
SRTS : 8.96 (+1.24%)
The Zacks Analyst Blog Highlights TransMedics, PROCEPT BioRobotics and Sensus Healthcare

TransMedics, PROCEPT BioRobotics and Sensus Healthcare are part of the Zacks top Analyst Blog Highlights.

SRTS : 8.96 (+1.24%)
TMDX : 66.13 (-1.25%)
PRCT : 37.53 (-3.72%)
3 Resilient Medical Stocks to Watch as Rate Hikes Continue

Here we discuss three Medical-Instruments stocks - TMDX, PRCT & SRTS - that continued to grow in the first nine months of 2022 even though three Fed rate hikes dragged broader indices down.

SRTS : 8.96 (+1.24%)
TMDX : 66.13 (-1.25%)
PRCT : 37.53 (-3.72%)
EDAP TMS S.A. (EDAP) Moves 7.3% Higher: Will This Strength Last?

EDAP TMS S.A. (EDAP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase...

EDAP : 10.79 (+0.09%)
SRTS : 8.96 (+1.24%)

Barchart Exclusives

2 Unusually Active Tesla Call Options. Only 1 Is a Buy
Two Tesla call options expiring in March 2024 exhibited unusual options activity Wednesday. Only one of them is a buy.    Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar